Regulation of cellular iron metabolism and its implications in lung cancer progression

Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized Therapy

(2014) Kalliopi Domvri et al.   Journal of Cancer

Mechanical regulation of cancer cell apoptosis and autophagy: Roles of bone morphogenetic protein receptor, Smad1/5, and p38 MAPK

(2013) Sheng-Chieh Lien et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Bone Morphogenetic Protein Type I Receptor Antagonists Decrease Growth and Induce Cell Death of Lung Cancer Cell Lines

(2013) Elaine Langenfeld et al.   PLoS One

Increased hepcidin expression in non-small cell lung cancer tissue and serum is associated with clinical stage

(2013) Qian Chen et al.   Thoracic Cancer

Epidemiology of Lung Cancer

(2013) Carole Ridge et al.   SEMINARS IN INTERVENTIONAL RADIOLOGY

Iron Chelators for the Treatment of Cancer

(2012) Y. Yu et al.   CURRENT MEDICINAL CHEMISTRY

Runx2 mediates epigenetic silencing of the bone morphogenetic protein-3B (BMP-3B/GDF10) in lung cancer cells

(2012) Manish Tandon et al.   Molecular Cancer

Advancement of the study on iron metabolism and regulation in tumor cells

(2012) Shu-Jun Wang et al.   Chinese Journal of Cancer

Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice

(2011) A. U. Steinbicker et al.   BLOOD

Bp44mT: an orally active iron chelator of the thiosemicarbazone class with potent anti-tumour efficacy

(2011) Y Yu et al.   BRITISH JOURNAL OF PHARMACOLOGY

The role of iron in tumour cell proliferation

(2011) Juan Luis Steegmann-Olmedillas   Clinical & Translational Oncology

Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice

(2011) Emilio Ramos et al.   HEPATOLOGY

Lung Tumor-associated Osteoblast-derived Bone Morphogenetic Protein-2 Increased Epithelial-to-Mesenchymal Transition of Cancer by Runx2/Snail Signaling Pathway

(2011) Ya-Ling Hsu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The serum bone morphogenetic protein-2 level in non-small-cell lung cancer patients

(2011) Yoon Ji Choi et al.   MEDICAL ONCOLOGY

The Hepcidin-Ferroportin System as a Therapeutic Target in Anemias and Iron Overload Disorders

(2011) T. Ganz et al.   Hematology-American Society of Hematology Education Program

Hepcidin and Disorders of Iron Metabolism

(2010) Tomas Ganz et al.   Annual Review of Medicine

Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice

(2010) T. B. Bartnikas et al.   BLOOD

Suppression of hepatic hepcidin expression in response to acute iron deprivation is associated with an increase of matriptase-2 protein

(2010) A.-S. Zhang et al.   BLOOD

A Mammalian Siderophore Synthesized by an Enzyme with a Bacterial Homolog Involved in Enterobactin Production

(2010) Laxminarayana R. Devireddy et al.   CELL

Genetic Determinants of Pemetrexed Responsiveness and Nonresponsiveness in Non-small Cell Lung Cancer Cells

(2010) Ming-Fang Wu et al.   Journal of Thoracic Oncology

Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis

(2010) Z. K. Pinnix et al.   Science Translational Medicine

Maintaining Mammalian Iron and Oxygen Homeostasis

(2009) Ameen A. Salahudeen et al.   Annals of the New York Academy of Sciences

Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma

(2009) Takao Kamai et al.   BMC CANCER

Interaction of the Hereditary Hemochromatosis Protein HFE with Transferrin Receptor 2 Is Required for Transferrin-Induced Hepcidin Expression

(2009) Junwei Gao et al.   Cell Metabolism

Intricacies of BMP receptor assembly

(2009) Joachim Nickel et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes

(2009) G. Ramey et al.   HAEMATOLOGICA

Bone morphogenetic protein receptors and signal transduction

(2009) K. Miyazono et al.   JOURNAL OF BIOCHEMISTRY

Altered iron metabolism, inflammation, transferrin receptors, and ferritin expression in non-small-cell lung cancer

(2009) Suzana Kukulj et al.   MEDICAL ONCOLOGY

Bone morphogenetic protein-2 levels are elevated in the patients with gastric cancer and correlate with disease progression

(2009) Yong Park et al.   MEDICAL ONCOLOGY

BMP-2 signaling in ovarian cancer and its association with poor prognosis

(2009) Cécile Le Page et al.   Journal of Ovarian Research

Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin

(2008) Y. Xia et al.   BLOOD

Immunoassay for human serum hepcidin

(2008) T. Ganz et al.   BLOOD

Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma

(2008) Hiroaki Kijima et al.   BMC CANCER

The Transferrin Receptor Modulates Hfe-Dependent Regulation of Hepcidin Expression

(2008) Paul J. Schmidt et al.   Cell Metabolism

Post-transcriptional Modulation of Iron Homeostasis during p53-dependent Growth Arrest

(2008) Fan Zhang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response

(2008) A. Swarbrick et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

SELDI-TOF-MS determination of hepcidin in clinical samples using stable isotope labelled hepcidin as an internal standard

(2008) Douglas G Ward et al.   Proteome Science

Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site

(2007) Lan Lin et al.   BLOOD CELLS MOLECULES AND DISEASES

Impaired growth plate function in bmp-6 null mice

(2007) Mark J. Perry et al.   BONE